Related Experiment Video
Updated: Jun 24, 2026

Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing
Published on: October 19, 2013
The breast cancer somatic 'muta-ome': tackling the complexity
Andrew E Teschendorff1, Carlos Caldas
1Medical Genomics Group, Paul O'Gorman Building, UCL Cancer Institute, University College London, London, UK. aet21@cam.ac.uk
Breast cancer is complex, driven by numerous low-frequency somatic mutations. Understanding these genomic aberrations and pathways is key to identifying new subtypes and improving treatment.
Area of Science:
- Genomics
- Cancer Biology
- Bioinformatics
Background:
- Acquired somatic mutations drive ~90% of breast tumors, but only HER2 amplification defines a subtype.
- Current mutational profiling reveals a complex breast cancer 'mutational landscape' (muta-ome).
- This complexity includes abundant low-frequency mutations and numerous genomic aberrations per tumor.
Purpose of the Study:
- To explore the complexity of the breast cancer mutational landscape.
- To identify clinically relevant mutation patterns and potential new breast cancer subtypes.
- To highlight the need for pathway-centric and integrative analysis approaches.
Main Methods:
- Analysis of mutational profiling studies.
- Integration of genomic mutation data with biological knowledge databases.
- Review of structural features emerging from follow-up studies.
Main Results:
- Breast cancer exhibits a complex mutational landscape with many low-frequency mutations.
- Approximately 20-50 somatic genomic aberrations drive an average tumor.
- Links are emerging between somatic gene disruptions, inherited risk, and pathway involvement.
- Mutations show non-random distribution, implicating specific molecular pathways.
Conclusions:
- A shift from gene-centric to pathway-centric approaches is necessary for breast cancer research.
- Multi-dimensional integrative analyses combining mutational and functional profiles are crucial.
- Larger profiling studies using advanced sequencing technologies are needed to map the full landscape.
Related Concept Videos
Cancer
Cancers Originate from Somatic Mutations in a Single Cell
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancers Originate from Somatic Mutations in a Single Cell
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

